PSNL

PERSONALIS INC

PSNL·71535D106·US·Common Stock·Healthcare - Diagnostics & Research-Activist

PSNL (PERSONALIS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: ARK Investment Management LLC ($50.6M), AMERIPRISE FINANCIAL INC ($48.4M), BlackRock, Inc. ($34.3M). Net institutional sentiment: Mixed.

88
Holders
Avg rating(19 Elite)
$266.5M
Total Value
62% (98)
Fund Consensus
56 buying - 35 selling
PSNLSmart Money Verdict
View all
Held by 88 funds
19 elite
Who's Trading
ActivistLVLightspeed Venture Partners Select IV, L.P.2.0%Jun 10, 2026
ActivistDTDeep Track Capital, LP5.5%May 12, 2026
ActivistTRT. Rowe Price Investment Management, Inc.4.5%Apr 8, 2026
ActivistAmeriprise Financial, Inc.Ameriprise Financial, Inc.7.1%Feb 17, 2026
ActivistOHOrin Hirschman3.8%Jan 29, 2026
InsiderTATachibana AaronSell $14KJan 22, 2026
InsiderTATachibana AaronSell $1.1MNov 25, 2025
ActivistRSRed Sky Ventures LLC4.7%Nov 13, 2025
InsiderHMHall Christopher MSell $266KNov 3, 2025
InsiderTATachibana AaronSell $4KJul 28, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.9M(+0.8%)$50.6M0.4%-12.62%
35
Increased
7.6M(+20.8%)$48.4M0.0%+75.36%
35
Increased
5.4M(+1.3%)$34.3M0.0%+125.05%
29
Increased
3.5M(+7.3%)$22.2M0.0%+143.47%
31
New
2.9M$18.3M0.0%+62.28%
39
Increased
1.7M(+13.9%)$10.5M0.0%+82.16%
32
Decreased
1.3M(-0.0%)$8.3M0.0%+49.44%
0
Increased
1.1M(+8.0%)$7.2M0.0%+124.54%
30
Increased
1.1M(+8.4%)$6.8M0.0%+154.47%
30
Increased
737,132(+115.2%)$4.7M0.0%+90.52%
43
Increased
575,490(+2054.1%)$3.6M0.0%+64.12%
43
New
560,539$3.6M0.0%+62.28%
37
Unchanged
493,798$3.1M0.0%-57.36%
0
Decreased
484,270(-6.6%)$3.1M0.0%-6.26%
0
Decreased
484,270(-6.6%)$3.1M0.0%-6.79%
0
New
419,128$2.7M0.0%+62.28%
36
Increased
405,800(+14.3%)$2.6M0.0%+88.21%
30
Increased
383,503(+25.1%)$2.4M0.0%+108.47%
32
Increased
343,520(+11.3%)$2.2M0.0%+107.16%
29
New
339,508$2.2M0.0%+62.28%
36

Showing 1-20 of 98

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used